Accenture vs Amentum
ACN and AMTM side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACN and AMTM compare
Accenture is the larger company, worth 31 times as much as Amentum ($168B against $5.4B).
On earnings, Accenture is cheaper: it trades at 18.5× trailing earnings, against 26.4× for Amentum.
Amentum grew revenue faster over the last twelve months (11.4% versus 6.5% for Accenture).
Accenture keeps more of each dollar of sales as profit, with a net margin of 11.3% compared with 1.4% at Amentum.
Accenture pays a dividend yielding 2.0%; Amentum does not pay one.
Accenture scores higher on the StockData Score (19 against 9 for Amentum), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACN | AMTM |
|---|---|---|
| Size and price | ||
| Market cap | $168B | $5.4B |
| Share price | $250.49 | $21.95 |
| Change, 1 year | 1.6% | −4.4% |
| Change, 5 years | −32.3% | – |
| Beta (5Y) | 0.94 | 1.21 |
| Employees | 814K | 50K |
| StockData Score | ||
| Total score | 19 (better) | 9 |
| Valuation score | 4 | 4 |
| Growth score | 2 | 3 (better) |
| Performance score | 6 (better) | 1 |
| Health score | 5 (better) | 1 |
| Dividend score | 2 (better) | 0 |
| Valuation | ||
| P/E | 18.5× (better) | 26.4× |
| P/S | 2.3× | 0.4× (better) |
| P/B | 5.3× | 1.1× (better) |
| EV/EBITDA | 14.6× (better) | 14.8× |
| P/FCF | 14.4× | 11.3× (better) |
| PEG | 2.31 | – |
| FCF yield | 6.9% | 8.8% (better) |
| Fair value | $305.38 | $27.54 |
| Margin of safety | 18.0% | 20.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 6.5% | 11.4% (better) |
| Revenue growth, 5Y average | 8.0% | – |
| Net income growth (TTM) | 9.0% | 292% (better) |
| EPS growth (TTM) | 11.6% | 113% (better) |
| EPS growth, 5Y average | 8.2% | – |
| Profitability | ||
| Gross margin | 32.0% (better) | 10.2% |
| Operating margin | 15.4% (better) | 4.2% |
| Net margin | 11.3% (better) | 1.4% |
| FCF margin | 15.7% (better) | 3.4% |
| Return on equity | 26.7% (better) | 4.5% |
| Return on invested capital | 31.8% (better) | 5.5% |
| Financial health | ||
| Debt / equity | 0.32 (better) | 0.81 |
| Net debt / EBITDA | −0.24 | 5.65 (better) |
| Interest coverage | 37.6× | – |
| Current ratio | 1.43 | 1.52 (better) |
| Altman Z-score | 4.61 (better) | 2.02 |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 2.0% | – |
| Buyback yield | 4.5% | – |
| Shareholder yield | 6.5% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 73.1% | 89.6% |
| Held by insiders | 0.04% | 32.3% |
| Insider net buying, 12 months | −$11.9M | – |
| Superinvestors holding | 5 (better) | 1 |
| Short interest, % of float | 3.2% | 8.5% |
Go deeper
- ACN stock overview
- ACN income statement
- ACN valuation and score
- AMTM stock overview
- AMTM income statement
- AMTM valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.